Gastric Cancer

• CLINICAL_TRIALS withdrawal · 2016-02-15
  Clinical Trial Update: Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Phase 1, Phase 2]

  A phase 1/2 trial of Epirubicin (Pharmorubicin), Carboplatin (Paraplatin) and Capecitabine (Xeloda) for unresectable locally advanced or met…

• CLINICAL_TRIALS withdrawal · 2015-09-25
  Clinical Trial Update: Educational Brochure in Preparing Patients With Gastric Cancer and Their Caregivers for Recovery After Surgery [NA]

  This clinical trial update notes that the educational brochure study for patients with gastric cancer and their caregivers recovering from s…

• CLINICAL_TRIALS withdrawal · 2015-08-26
  Clinical Trial Update: huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas [Phase 2]

  This clinical trial update indicates that the Phase 2 study of huC242-DM4 for metastatic or locally advanced gastric and gastroesophageal ju…

• CLINICAL_TRIALS withdrawal · 2014-01-07
  Clinical Trial Update: A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen [Phase 2]

  Phase 2 trial comparing ARQ 197 (tivantinib) against investigator's choice second-line chemotherapy for locally advanced or metastatic gastr…

• CLINICAL_TRIALS withdrawal · 2013-08-05
  Clinical Trial Update: Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer [Phase 1]

  Phase 1 cancer vaccine trial for metastatic or recurrent cancer has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2012-09-14
  Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer [Phase 1]

  A Phase 1 trial evaluating radiolabeled monoclonal antibody therapy for gastrointestinal cancers has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2012-05-28
  Clinical Trial Update: Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

  A clinical trial on collection of biospecimens and clinical information from patients with gastrointestinal and gynecologic cancers was with…

• CLINICAL_TRIALS withdrawal · 2012-03-02
  Clinical Trial Update: Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer [Phase 1]

  A Phase 1 trial evaluating two-generation anti-CEA designer T cells for gastric cancer has been withdrawn. The sponsor is Roger Williams Med…

• CLINICAL_TRIALS withdrawal · 2009-02-17
  Clinical Trial Update: Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. [Phase 1, Phase 2]

  A Phase I/II study evaluating paclitaxel plus irinotecan (CPT-11) for second-line treatment in patients with inoperable or recurrent gastric…